维普期刊资源整合服务平台（V6.5）

230篇 您的检索式：作者名="HARRISON SA"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	基因工程FGF19类似物aldafermin治疗非酒精性脂肪性肝炎的效果和安全性显示文摘aldafermin是一种成纤维细胞生长因子19的工程类似物,可抑制胆汁酸的合成并调节代谢稳态。该研究报告了一项对非酒精性脂肪性肝炎(NASH)患者进行的一系列肝脏活检的为期24周的2期临床试验结果。	HARRISON SA NEFF G GUY CD 张瑞华温晓玉	2021	临床肝胆病杂志2021，37，3：	22
2	Liver disease in patients with diabetes mellitus 显示文摘	Harrison SA	2006	J Clin Gastroenterol2006，40，：	1
3	Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy显示文摘	Harrison SA Rossaro L Hu KQ		0，，3：	1
4	A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells显示文摘	Bader SA Walker M Harrison DJ	2007	Br J Cancer2007，96，4：	1
5	Current and e-merging therapies in nonalcoholic fatty liver disease显示文摘	KASHI MR TORRES DM HARRISON SA	2008	Se-min Liver Dis2008，28，3：	1
6	Pharmacologic management of nonalcoholic fatty liver disease显示文摘	HARRISON SA NEUSCHWANDER-TETRI BA	2004	Clin Liver Dis2004，8，3：	1
7	Fat and the liver - a molecular overview 显示文摘	Harrison SA Diehl AM	2002	Sere in Gastrointestin Dis2002，13，1：	1
8	Diagnosis and therapy of nonalcoholic steatohepatitis 显示文摘	Torres DM Harrison SA	2008	Gastroenterology2008，134，6：	1
9	Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis 显示文摘	Harrison SA Torgerson S Hayashi P	2003	Am J Gastroenterol2003，98，11：	1
10	Features, diagnosis, andtreatment of nonalcoholic fatty liver disease显示文摘	Torres DM Williams CD Harrison SA	2012	Clin GastroenterolHepatol2012，10，8：	1
11	Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association? 显示文摘	KWOK RM TORRES DM HARRISON SA	2013	Hepatology2013，58，3：	1
12	Nonalcoholic steatohepatitis: what we knowin the new millmniam 显示文摘	Harrison SA Kadakia S Lanug KA	2002	Am J Gastroentcrol2002，97，11：	1
13	Nonalcoholic steatohepatitis:what we know in the new millennium显示文摘	Harrison SA Kadakia S Lang KA	2002	Am J Gastroenterol2002，97，11：	1
14	Nonalcoholic steatohepatitis: what we know in the new millennium显示文摘	Harrison SA Kadakia S Lang KA	2002	Am J Gastrienterol2002，97，：	1
15	Anti-CCP antibody testing as a diagnostic and prog-nostic tool in rheumatoid arthritis显示文摘	Harrison MJ Paget SA	2007	QJM2007，100，4：	1
16	Fat and the liver amolecular overview显示文摘	Harrison SA Diehl AM	2002	Semin Gastrointest Dis2002，13，1：	1
17	Pioglitazone treatment increases whole body fat but not total body water in patients with non - alcoholic steatohepatitis 显示文摘	Balas B Belfort R Harrison SA	2007	J Hepatol2007，47，4：	1
18	New treatments for nonalcoholic fatty liver disease显示文摘	Harrison SA	2006	Curr Gastroenterol Rep2006，8，1：	1
19	Viral vectors in cancer immunotherapy:which vector for which strategy 显示文摘	Collins SA Guinn BA Harrison PT	2008	Curr Gene Ther2008，8，2：	1
20	Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera显示文摘	Schwartz SD Harrison SA Ferrone PJ	2000	Ophthalmology2000，107，：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示